The diagnostics firm was acquired at great cost, but is unable to support PharmEasy’s core online pharmacy business.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
Many companies are exploring the business opportunity that synthetic diamonds offer. It sure seems like an easy business to enter, but will everyone manage to scale it?
The packaged coffee startup came close to running out of money in 2023. A timely course correction and its founders’ doggedness helped pull the company back from the brink.
The seven-year-old health tech firm has hit a wall with its core surgery business. It is now opening up hospitals.